Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.

Christopher HohmannRoman PfisterChristian FrerkerAndreas BeckmannThomas WaltherSabine BleizifferStephan EnsmingerRaffi BekeredjianMoritz SeiffertJan-Malte SinningHelge MöllmannFriedhelm BeyersdorfStephan BaldusAndreas BöningEva HerrmannÜmniye BalabanElmar Kuhnnull null

Published in: Heart (British Cardiac Society) (2023)

This study supports evidence of the efficacy of DOAC use after TAVI in patients with an indication for oral anticoagulation.

Keyphrases

transcatheter aortic valve implantation
direct oral anticoagulants
venous thromboembolism
atrial fibrillation
aortic valve
aortic valve replacement
aortic stenosis
transcatheter aortic valve replacement
heart failure
ejection fraction
left ventricular
coronary artery disease